FIELD: medicine.
SUBSTANCE: invention relates to molecular genetic diagnostics in oncology, and can be used for prediction of risk of prostate cancer. What is presented is a method for predicting the risk of developing prostate cancer. Deoxyribonucleic acid DNA is recovered from peripheral venous blood. Then SNP single-nucleotide polymorphisms are analyzed: rs4430796 of the HNF1B gene C>T, rs1859962 of the CASC17 gene A>C, rs1447295 of the CASC8 gene G>T, rs6983267 CCAT2 G>T. A genomic combination is determined by a combination of alleles of the listed genes. When detecting genomic combinations of alleles of these genes: TT CC GG G/T; TT CC G/T TT; TT AA GG G/T; TT AA G/T G/T; TT AA G/T GG; TT AA G/T TT; TT A/C GG G/T; CC CC G/T G/T; CC AA GG GG; CC CC GG GG; CC CC GG TT; CC AA GG G/T—high risk of developing prostate cancer is predicted.
EFFECT: development of informative diagnostic method enables to identify patients with increased risk of prostate cancer on the basis of analysis of four single-nucleotide polymorphisms simultaneously.
1 cl, 5 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF RISK OF DEVELOPING BREAST CANCER IN WOMEN WITHOUT OBESITY BY RESULTS OF GENETIC TESTING | 2024 |
|
RU2828525C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING LUMINAL SUBTYPE OF BREAST CANCER IN WOMEN | 2024 |
|
RU2828523C1 |
METHOD FOR PREDICTION OF DEVELOPING MALIGNANT GROWTHS IN RADIATION EXPOSURE | 2012 |
|
RU2521393C2 |
METHOD FOR PREDICTION OF NEWBORN'S WEIGHT BASED ON GENETIC DATA OF MOTHERS | 2023 |
|
RU2818358C1 |
METHOD FOR PREDICTING AN INCREASED RISK OF DEVELOPING CHRONIC TRUE ECZEMA IN MEN USING DATA ON FILAGGRIN GENE POLYMORPHISM | 2021 |
|
RU2750963C1 |
METHOD FOR PREDICTION OF GROWTH OF NEWBORNS USING DATA ON GENETIC POLYMORPHISM OF MOTHERS | 2023 |
|
RU2820498C1 |
EARLY DNA-DIAGNOSTIC TECHNIQUE OF PROSTATE CANCER | 2009 |
|
RU2405837C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING BREAST CANCER IN WOMEN BASED ON DATA ON INTERLOCUS INTERACTIONS | 2023 |
|
RU2815932C1 |
METHOD FOR PREDICTION OF INCREASED RICK OF DEVELOPING STAGE 1-2 BREAST CANCER IN WOMEN BASED ON POLYMORPHISM OF THE MATRIX METALLOPROTEINASE 9 GENE | 2022 |
|
RU2795100C1 |
VEGF POLYMORPHISM AND ANTIANGIOGENESIS THERAPY | 2008 |
|
RU2482491C2 |
Authors
Dates
2024-09-23—Published
2023-12-22—Filed